Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$784M |
| 2 |
Apple
AAPL
|
+$427M |
| 3 |
Danaher
DHR
|
+$417M |
| 4 |
Prologis
PLD
|
+$405M |
| 5 |
Amazon
AMZN
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$587M |
| 2 |
Eli Lilly
LLY
|
+$491M |
| 3 |
DRE
Duke Realty Corp.
DRE
|
+$343M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$252M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.94% |
| 2 | Healthcare | 15.43% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
Greenwich LifeSciences
GLSI
$211M
| $606K | ﹤0.01% |
39,933
-2,326
| -6% | -$26.6K |
|
3577
Gencor Industries
GENC
$212M
| $600K | ﹤0.01% |
59,481
+1,213
| +2% | +$12.1K |
|
3578
Landmark Bancorp
LARK
$195M
| $600K | ﹤0.01% |
30,741
+942
| +3% | +$19.6K |
|
3579
NN Inc
NNBR
$311M
| $599K | ﹤0.01% |
399,896
+4,216
| +1% | +$7.81K |
|
3580
Flotek Industries
FTK
$1.28B
| $598K | ﹤0.01% |
89,072
-5,736
| -6% | -$39.9K |
|
|
PEPL
3581
DELISTED
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
| $598K | ﹤0.01% |
58,596
+10,096
| +21% | +$102K |
|
3582
Talkspace
TALK
$874M
| $597K | ﹤0.01% |
978,272
+10,573
| +1% | +$8.13K |
|
3583
BioVie
BIVI
$7.54M
| $595K | ﹤0.01% |
766
+372
| +94% | +$201K |
|
|
GAN
3584
DELISTED
GAN Ltd
GAN
| $594K | ﹤0.01% |
396,451
+4,884
| +1% | +$8.21K |
|
|
CLSD
3585
DELISTED
Clearside Biomedical
CLSD
| $593K | ﹤0.01% |
35,340
+320
| +0.9% | +$5.76K |
|
3586
Lulu's Fashion Lounge
LVLU
$52.3M
| $593K | ﹤0.01% |
15,757
+778
| +5% | +$52.4K |
|
3587
SurgePays
SURG
$7.27M
| $592K | ﹤0.01% |
90,355
-10,631
| -11% | -$64.2K |
|
|
CS
3588
DELISTED
Credit Suisse Group
CS
| $591K | ﹤0.01% |
194,628
| – | – |
|
3589
Assembly Biosciences
ASMB
$529M
| $588K | ﹤0.01% |
37,719
-76
| -0.2% | -$1.3K |
|
3590
Heritage Global
HGBL
$36.8M
| $588K | ﹤0.01% |
250,316
+7,389
| +3% | +$15.4K |
|
|
MSDA
3591
DELISTED
MSD Acquisition Corp. Class A Ordinary Shares
MSDA
| $587K | ﹤0.01% |
58,137
+17,515
| +43% | +$175K |
|
3592
Annovis Bio
ANVS
$80M
| $584K | ﹤0.01% |
43,558
+1,262
| +3% | +$15.8K |
|
3593
X4 Pharmaceuticals
XFOR
$460M
| $583K | ﹤0.01% |
19,584
+3,129
| +19% | +$148K |
|
3594
Galectin Therapeutics
GALT
$348M
| $580K | ﹤0.01% |
513,815
-87
| -0% | -$116 |
|
|
USAP
3595
DELISTED
Universal Stainless & Alloy
USAP
| $579K | ﹤0.01% |
80,876
+468
| +0.6% | +$3.37K |
|
3596
Cardiff Oncology
CRDF
$77.2M
| $578K | ﹤0.01% |
413,502
-870
| -0.2% | -$1.25K |
|
|
IMPL
3597
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $578K | ﹤0.01% |
154,238
+5,592
| +4% | +$20.4K |
|
3598
Eldorado Gold
EGO
$9.89B
| $577K | ﹤0.01% |
69,263
-655
| -0.9% | -$4.64K |
|
|
HOLI
3599
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $577K | ﹤0.01% |
35,132
| – | – |
|
3600
Cytosorbents Corp
CTSO
$22.6M
| $576K | ﹤0.01% |
371,708
+3,189
| +0.9% | +$4.73K |
|
Similar funds
Geode Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Geode Capital Management held 5,090 positions worth $713B, up 8.1% from $659B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q4 2022: portfolio turnover was 4.9%. Geode Capital Management opened 62 new positions and exited 188, leaving the 5,090-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2022 buy was Ferguson: 1,854,192 shares worth $235M.
- Geode Capital Management added most to Microsoft in Q4 2022, an estimated $784M increase.
- Geode Capital Management's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $491M.
- Geode Capital Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $587M.
- Geode Capital Management's ten largest holdings make up 20% of its $713B portfolio in Q4 2022.
- Geode Capital Management opened 62 new positions and closed 188 in Q4 2022.
- Geode Capital Management's portfolio value rose 8.1% quarter-over-quarter to $713B.
Based on Geode Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.